Results for tag: "Guillain Barre Syndrome Drug"

The Guillain Barre Syndrome Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat Guillain Barre Syndrome, a rare autoimmune disorder that affects the peripheral nervous system. The drugs used to treat this disorder are typically immunomodulatory agents, such as intravenous immunoglobulin, plasma exchange, and corticosteroids. These drugs are used to reduce inflammation and suppress the immune system, allowing the body to recover from the disorder. The Guillain Barre Syndrome Drug market is highly competitive, with many companies offering treatments for the disorder. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies, such as Biogen, AbbVie, and Johnson & Johnson, also offer treatments for the disorder. Show Less Read more